Advapro Coronary Stent System in Coronary Artery Diseased Patients.

Exclusion Criteria

• •Ethical : Pregnant and lactating females
• •Patients requiring staged procedure
• •Condition : Known congestive heart failure (NYHA IV) or left ventricular ejection fraction (LVEF) \<30%
• •Condition : Patients with known hypersensitivity or allergies to aspirin, heparin, clopidogrel, ticlopidine, Sirolimus or similar drugs, or any other analogue or derivative, cobalt, chromium, nickel, molybdenum or contrast media
• •Condition : Current medical condition with a life expectancy of less than 12 months
• •Condition : Diagnosis: Acute Myocardial Infarction within 72 hours of Planned Index procedure
• •Condition : Patient has current unstable arrhythmias
• •Procedural : Patients previously treated with PCI or CABG for any coronary artery lesion revascularization
• •Procedural : Patients with Chronic Total Occlusion in two or more vessels
• •Procedural : Patients with Ostial lesions (within 5.0mm of vessel origin).
• •Procedural : Patients with Bifurcation lesions that include a side branch \>2.0 mm diameter
• •Procedural : Unprotected Left Main Coronary Artery lesion
• •Condition : Heavily calcified lesion and/or calcified lesion which cannot be successfully predilated in opinion of the treating cardiologist
• •Condition : Patients with Cardiogenic shock, systemic bleeding and coagulation disorders, intracranial bleeding, Renal insufficiency requiring dialysis, Acute or chronic renal function (serum creatinine \>2.0mg/dl or 150 µmol/L), peripheral vascular diseases, cancer, etc. and patients who are planning to undergo surgery within 1 year of the index procedure
• •Condition : Patients with platelet count \<100.000 cells/mm3 or \>700.000 cells/mm3 or a WBC \<3.000 cells/mm3